Abstract Circulating cell-free DNA (cfDNA) is a versatile biomarker in oncology, prenatal testing, and organ transplantation. Although cfDNA concentration and genomic markers are widely used, its fragment size distribution (fragmentome) offers additional diagnostic potential. However, robust reference profiles for healthy individuals—particularly for fragments exceeding 300 bp—remain lacking.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Pascal Pedini
Third-Generation Nanopore Sequencing for Post-Transplant Chimerism Monitoring
ddPCR Droplet digital PCR dPCR Digital PCR EQA external quality assessment HSCT Hematopoietic stem cell transplantation INDEL Insertion/Deletion NGS Next generation sequencing qPCR quantitative PCR SNP Single nucleotide polymorphism STR Short tandem repeat TGS Third-generation sequencing 1 Introduction Monitoring post-transplant chimerism following hematopoietic stem cell transplantation (HSCT) is a key indicator of engraftment success, enabling the early detection of graft rejection or...
Characterisation of the Novel HLA‐B*18:247 Allele Using New Next‐Generation Sequencing Methods
Please review our Terms and Conditions of Use and check box below to share full-text version of article. I have read and accept the Wiley Online Library Terms and Conditions of Use Use the link below to share a full-text version of this article with your friends and colleagues. Learn more.
Prospective Study of Recipient Human Leukocyte Antigen (HLA) Alloimmunization Following the Use of Cold-Stored Saphenous Vein Allografts in Vascular Surgery
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
In 2019, 10,000 venous allografts cryopreserved between +2°C and +8°C (CPVA) were implanted in France, particularly in to create hemodialysis accesses in patients who were waiting for a renal transplant and in whom the development of anti-HLA antibodies (DSA) could lead to an increased risk of rejection. It is recognized that the endothelium of these CPVAs is destroyed during implantation and that they are not likely to cause an immune reaction in the recipient.
Strong humoral response after Covid‐19 vaccination correlates with the common HLA allele A*03:01 and protection from breakthrough infection
CONFLICT OF INTEREST STATEMENT The authors declare no conflicts of interest. Supporting Information Filename Description tan15421-sup-0001-TableS1.docxWord 2007 document , 34.5 KB Supplemental Table S1: Frequencies and ranking of the HLA alleles found in samples of weak and strong responders and in the Italian population. REFERENCES 1, , , et al. Determinants of anti-S immune response at 6 months after COVID-19 vaccination in a multicentric European cohort of healthcare workers - ORCHESTRA project.
Low Prevalence of HLA-G Antibodies in Lung Transplant Patients Detected using MAIPA-Adapted Protocol
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Comparison of HLA antibody identification methods for the selection of platelet products for HLA‐mediated platelet refractory patients
CDC complement-dependent lymphocytotoxicity CPRA calculated panel reactive antibody HLA human leukocyte antigen HSCT hematopoietic stem cell transplantation MFI mean fluorescence intensity PRAs panel reactive antibodies SA single antigen 1 INTRODUCTION Currently, refractory status remains the major problem of platelet transfusions in patients suffering from hematological diseases or aplasia.
Characterization of the novel HLA‐A*33:246 allele using next‐generation sequencing
Please review our Terms and Conditions of Use and check box below to share full-text version of article. I have read and accept the Wiley Online Library Terms and Conditions of Use Use the link below to share a full-text version of this article with your friends and colleagues. Learn more.
Low prevalence of HLA-G antibodies in lung transplant patients detected by MAIPA adapted protocol
Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Pascal
Contact Pascal, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack